{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:42:14Z","timestamp":1789004534034,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025249","name":"Djavad Mowafaghian Centre for Brain Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-195977"],"award-info":[{"award-number":["PJT-195977"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000143","name":"Alzheimer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005309","name":"Alzheimer Society of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.molpha.2025.100027","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:07:08Z","timestamp":1740769628000},"page":"100027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7995-459X","authenticated-orcid":false,"given":"Keren","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-1975","authenticated-orcid":false,"given":"Khaled S.","family":"Abd-Elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2025.100027_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner","volume":"13","author":"Abd-Elrahman","year":"2020","journal-title":"Sci Signal"},{"key":"10.1016\/j.molpha.2025.100027_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116388","article-title":"A\u00a0M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female Alzheimer\u2019s mice","volume":"173","author":"Abd-Elrahman","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.molpha.2025.100027_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","article-title":"Noncanonical metabotropic glutamate receptor 5 signaling in Alzheimer\u2019s disease","volume":"62","author":"Abd-Elrahman","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.molpha.2025.100027_bib4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/bph.15750","article-title":"A\u00a0positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe\/PSEN1\u0394E9 mice","volume":"179","author":"Abd-Elrahman","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100027_bib5","doi-asserted-by":"crossref","unstructured":"Ahuja A, Patel P, and Abdijadid S. Benztropine (2024) XPharm: The Comprehensive Pharmacology Reference 1\u20134. https:\/\/doi.org\/10.1016\/B978-008055232-3.61299-1","DOI":"10.1016\/B978-008055232-3.61299-1"},{"key":"10.1016\/j.molpha.2025.100027_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.molpha.2025.100027_bib81","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/mcne.2001.1042","article-title":"M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices","volume":"18","author":"Berkeley","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib7","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.1016\/S0021-9258(18)42410-6","article-title":"Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq\/11, and phospholipase C-beta 1","volume":"267","author":"Berstein","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2025.100027_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrneurol.2013.225","article-title":"Drug-enhanced remyelination in a multiple sclerosis model","volume":"9","author":"Bible","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-5728(99)00083-1","article-title":"The origin of remyelinating cells in the central nervous system","volume":"98","author":"Blakemore","year":"1999","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.molpha.2025.100027_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrn3900","article-title":"Exploring the origins of grey matter damage in multiple sclerosis","volume":"16","author":"Calabrese","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib11","first-page":"2887","article-title":"Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation","volume":"10","author":"Calabresi","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/dneu.20976","article-title":"Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation","volume":"72","author":"De Angelis","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.molpha.2025.100027_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A\u00a0regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100027_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0773.1996.tb00181.x","article-title":"Selective muscarinic receptor agonists and antagonists","volume":"78","author":"Eglen","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.molpha.2025.100027_bib15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/glia.23629","article-title":"Axoglial interactions in myelin plasticity: Evaluating the relationship between neuronal activity and oligodendrocyte dynamics","volume":"67","author":"Foster","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.molpha.2025.100027_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2014from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.molpha.2025.100027_bib18","first-page":"327","article-title":"Oligodendrocyte development and regenerative therapeutics in multiple sclerosis","volume":"11","author":"Gacem","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.molpha.2025.100027_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2016.03.008","article-title":"Intracellular signaling pathway regulation of myelination and remyelination in the CNS","volume":"283","author":"Gaesser","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuropharm.2015.04.024","article-title":"The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination","volume":"110","author":"Gonsalvez","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molpha.2025.100027_bib21","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.molpha.2025.100027_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.molpha.2025.100027_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(03)00810-9","article-title":"F3\/contactin acts as a functional ligand for notch during oligodendrocyte maturation","volume":"115","author":"Hu","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100027_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.molpha.2025.100027_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111481","article-title":"The preferential effect of Clemastine on F3\/Contactin-1\/Notch-1 compared to Jagged-1\/Notch-1 justifies its remyelinating effect in an experimental model of multiple sclerosis in rats","volume":"128","author":"Ibrahim","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.molpha.2025.100027_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nm781","article-title":"Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation","volume":"8","author":"John","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.molpha.2025.100027_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-53615-x","article-title":"Clemastine and metformin extend the window of NMDA receptor surface expression in ageing oligodendrocyte precursor cells","volume":"14","author":"Kamen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.molpha.2025.100027_bib29","article-title":"Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis","author":"Kocot","year":"2024","journal-title":"MedRxiv"},{"key":"10.1016\/j.molpha.2025.100027_bib30","article-title":"Physiology, muscarinic receptor","author":"Kudlak","year":"2023","journal-title":"StatPearls"},{"key":"10.1016\/j.molpha.2025.100027_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib32","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molpha.2025.100027_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010230","article-title":"A\u00a0universal pharmacological-based list of drugs with anticholinergic activity","volume":"15","author":"Lavrador","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.molpha.2025.100027_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0024-3205(93)90300-R","article-title":"Immunological localization of m1\u2013m5 muscarinic acetylcholine receptors in peripheral tissues and brain","volume":"52","author":"Levey","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.molpha.2025.100027_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10571-021-01089-0","article-title":"The notch signaling pathway regulates differentiation of NG2 cells into oligodendrocytes in demyelinating diseases","volume":"42","author":"Li","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.molpha.2025.100027_bib36","article-title":"Quetiapine","author":"Maan","year":"2023","journal-title":"StatPearls"},{"key":"10.1016\/j.molpha.2025.100027_bib37","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1073\/pnas.95.19.11465","article-title":"Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells","volume":"95","author":"Marino","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.molpha.2025.100027_bib38","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/brain\/awad421","article-title":"p38\u03b3 MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions","volume":"147","author":"Marziali","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.molpha.2025.100027_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.608491","article-title":"Deciphering multiple sclerosis progression","volume":"12","author":"Meca-Lallana","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.molpha.2025.100027_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"ELife"},{"key":"10.1016\/j.molpha.2025.100027_bib42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acsptsci.9b00068","article-title":"Remyelination pharmacotherapy investigations highlight diverse mechanisms underlying multiple sclerosis progression","volume":"2","author":"Melchor","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.molpha.2025.100027_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.94.15_supplement.2868","article-title":"Quetiapine is not tolerable to people with MS in doses potentially required to enhance myelin repair (2868)","volume":"94","author":"Metz","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.molpha.2025.100027_bib44","first-page":"1","article-title":"Clemastine","author":"Minigh","year":"2008","journal-title":"XPharm: The Comprehensive Pharmacology Reference"},{"key":"10.1016\/j.molpha.2025.100027_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115435","article-title":"Modulation of p38 MAPK and Nrf2\/HO-1\/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of clemastine in EAE rat model","volume":"209","author":"Motawi","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molpha.2025.100027_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.01.002","article-title":"Dynamic ligand discrimination in the Notch signaling pathway","volume":"172","author":"Nandagopal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100027_bib47","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1177\/1352458519884006","article-title":"Remyelination and ageing: reversing the ravages of time","volume":"25","author":"Neumann","year":"2019","journal-title":"Mult Scler J"},{"key":"10.1016\/j.molpha.2025.100027_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/life11030231","article-title":"Interaction between neurons and the oligodendroglial lineage in multiple sclerosis and its preclinical models","volume":"11","author":"Pantazou","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.molpha.2025.100027_bib49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00020.2014","article-title":"Store-operated calcium channels","volume":"95","author":"Prakriya","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molpha.2025.100027_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005072-199301000-00007","article-title":"The potential for oligodendrocyte proliferation during demyelinating disease","volume":"52","author":"Prayoonwiwat","year":"1993","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib51","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020\u20132060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.molpha.2025.100027_bib52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0024-3205(97)00054-4","article-title":"The M5 (m5) receptor subtype: fact or fiction?","volume":"60","author":"Reever","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.molpha.2025.100027_bib82","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1523\/JNEUROSCI.20-03-00977.2000","article-title":"ERKI\/II regulation by the muscarinic acetylcholine receptors in neurons","volume":"20","author":"Rosenblum","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib53","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1523\/JNEUROSCI.1862-17.2018","article-title":"Muscarinic receptor M3R signaling prevents efficient remyelination by human and mouse oligodendrocyte progenitor cells","volume":"38","author":"Ross Welliver","year":"2018","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib54","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neuron.2017.11.026","article-title":"White matter plasticity in the adult brain","volume":"96","author":"Sampaio-Baptista","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100027_bib55","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cellsig.2014.01.010","article-title":"G\u03b1q signalling: the new and the old","volume":"26","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.molpha.2025.100027_bib56","first-page":"161","article-title":"Discovery of PIPE-359, a brain-penetrant, selective M1 receptor antagonist with robust efficacy in murine MOG-EAE","volume":"12","author":"Schrader","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.molpha.2025.100027_bib57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.06.047","article-title":"Regulation of conduction time along axons","volume":"276","author":"Seidl","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.molpha.2025.100027_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-10095-1","article-title":"Oscillatory calcium release and sustained store-operated oscillatory calcium signaling prevents differentiation of human oligodendrocyte progenitor cells","volume":"12","author":"Seidman","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.molpha.2025.100027_bib59","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbagen.2013.11.015","article-title":"Frequency decoding of calcium oscillations","volume":"1840","author":"Smedler","year":"2014","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.molpha.2025.100027_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuron.2018.12.020","article-title":"Oligodendrocyte progenitor cells become regionally diverse and heterogeneous with age","volume":"101","author":"Spitzer","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100027_bib61","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/glia.23606","article-title":"Inhibition of MAPK\/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases","volume":"67","author":"Suo","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.molpha.2025.100027_bib62","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/acn3.51401","article-title":"Mechanistic underpinning of an inside\u2013out concept for autoimmunity in multiple sclerosis","volume":"8","author":"\u2019t Hart","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.molpha.2025.100027_bib63","article-title":"Multiple sclerosis","author":"Tafti","year":"2024","journal-title":"StatPearls"},{"key":"10.1016\/j.molpha.2025.100027_bib64","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/cells8101236","article-title":"From OPC to oligodendrocyte: an epigenetic journey","volume":"8","author":"Tiane","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molpha.2025.100027_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.914153","article-title":"Clemastine promotes differentiation of oligodendrocyte progenitor cells through the activation of ERK1\/2 via muscarinic receptors after spinal cord injury","volume":"13","author":"Tong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molpha.2025.100027_bib66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1126\/science.aad3839","article-title":"Oligodendrocyte precursors migrate along vasculature in the developing nervous system","volume":"351","author":"Tsai","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100027_bib67","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1086\/515546","article-title":"Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold","volume":"25","author":"Turner","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.molpha.2025.100027_bib68","article-title":"Fine-tuning muscarinic acetylcholine receptor signaling through allostery and bias","volume":"11","author":"van der Westhuizen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molpha.2025.100027_bib69","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.molpha.2025.100027_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0896-6273(00)80515-2","article-title":"Notch receptor activation inhibits oligodendrocyte differentiation","volume":"21","author":"Wang","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100027_bib71","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3390\/cimb44050149","article-title":"A\u00a0glance at the molecules that regulate oligodendrocyte myelination","volume":"44","author":"Wang","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.molpha.2025.100027_bib83","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nn.4351","article-title":"Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning","volume":"19","author":"Xiao","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.molpha.2025.100027_bib72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.mp.4002064","article-title":"Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes","volume":"13","author":"Xiao","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.molpha.2025.100027_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.733945","article-title":"Clemastine ameliorates myelin deficits via preventing senescence of oligodendrocyte precursor cells in Alzheimer\u2019s disease model mouse","volume":"9","author":"Xie","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.molpha.2025.100027_bib74","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0813-8","article-title":"Structural basis of Notch recognition by human \u03b3-secretase","volume":"565","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100027_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100027_bib76","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2014.10.011","article-title":"Dynamics of oligodendrocyte generation and myelination in the human brain","volume":"159","author":"Yeung","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100027_bib77","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3390\/ijms24076373","article-title":"Mechanisms of demyelination and remyelination strategies for multiple sclerosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molpha.2025.100027_bib78","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cns.12154","article-title":"Quetiapine fumarate for the treatment of multiple sclerosis: Focus on myelin repair","volume":"19","author":"Zhornitsky","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.molpha.2025.100027_bib79","first-page":"1","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.molpha.2025.100027_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106375","article-title":"Clemastine-induced enhancement of hippocampal myelination alleviates memory impairment in mice with chronic pain","volume":"190","author":"Zhu","year":"2024","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25152875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25152875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:51:57Z","timestamp":1762213917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25152875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0026895X25152875"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100027","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100027"}}